Ginkgo Bioworks Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Ginkgo Bioworks (NYSE: DNA), a company focused on cell programming and biosecurity, announced that its Co-Founder and CEO Jason Kelly will present at the 43rd Annual J.P. Morgan Healthcare Conference. The presentation is scheduled for Thursday, January 16, 2025, at 10:30 a.m. PT (1:30 p.m. ET). A webcast link and replay will be available on the company's investor relations website.

BOSTON, Jan. 9, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that Co-Founder and CEO, Jason Kelly, is scheduled to present at the 43rd Annual J.P. Morgan Healthcare Conference on Thursday, January 16, 2025 at 10:30 a.m. PT (1:30 p.m. ET).

Further details, a webcast link, and a replay of the presentation will be posted on the company's investor relations website at https://investors.ginkgobioworks.com/events.

About Ginkgo Bioworks

Ginkgo Bioworks is the leading horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Ginkgo Biosecurity is building and deploying the next-generation infrastructure and technologies that global leaders need to predict, detect, and respond to a wide variety of biological threats. For more information, visit ginkgobioworks.com and ginkgobiosecurity.com, read our blog, or follow us on social media channels such as X (@Ginkgo and @Ginkgo_Biosec), Instagram (@GinkgoBioworks), Threads (@GinkgoBioworks), or LinkedIn.

Ginkgo Bioworks Contacts:

INVESTOR CONTACT:
investors@ginkgobioworks.com

MEDIA CONTACT:
press@ginkgobioworks.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/ginkgo-bioworks-announces-participation-in-the-43rd-annual-jp-morgan-healthcare-conference-302346539.html

SOURCE Ginkgo Bioworks

FAQ

When is Ginkgo Bioworks (DNA) presenting at the 2025 J.P. Morgan Healthcare Conference?

Ginkgo Bioworks is scheduled to present on Thursday, January 16, 2025, at 10:30 a.m. PT (1:30 p.m. ET).

Where can investors watch Ginkgo Bioworks' (DNA) J.P. Morgan Healthcare Conference presentation?

Investors can access the webcast and replay of the presentation through Ginkgo Bioworks' investor relations website at investors.ginkgobioworks.com/events.

Who will represent Ginkgo Bioworks (DNA) at the 2025 J.P. Morgan Healthcare Conference?

Co-Founder and CEO Jason Kelly will represent Ginkgo Bioworks at the conference.

Which annual J.P. Morgan Healthcare Conference is Ginkgo Bioworks (DNA) participating in for 2025?

Ginkgo Bioworks is participating in the 43rd Annual J.P. Morgan Healthcare Conference.